No-Prophylaxis
Prophylaxis
P value
Number of patients Autologous Allogeneic
119 73 46
100 51 49
0.124
Age Median(range)
45 years (2 to 68 years)
34.5 (1 to 68years)
0.005
Diagnosis
Diagnosis
Diagnosis
Diagnosis
Autologous Myeloma Lymphoma Others
51 14 4
35 11 1
 
Allogeneic Leukemia MDS MPN Haemoglobinopathies Aplastic Anemia Others
24 3 2 13 5 3
15 3 1 15 8 8
 
Conditioning regimen Myeloablative Reduced intensity
95 (79.8%) 24 (20.2%)
86 (86%) 14 (14%)
 
Allogeneic transplant Matched Sibling Donor Matched unrelated Donor Haploidentical
46 31 (67.4%) 5 (10.9%) 10 (21.7%)
49 40 (81.6%) 4 (8.2%) 5 (10.2%)
 
CD 34 dose Median (range)
5.10 x 106/kg (2.0 to 23.0x 106/kg)
3.91x 106/kg (1.0 to 17.0x 106/kg)
0.111
Neutrophil engraftment Median(range)
11 Days (12 to 31 Days)
12 Days (9 to 35 Days)
0.024
Platelet engraftment Median(range)
11 Days (12 to 25 Days)
12 (10 to 117 Days)
0.004
Hospital stay Median (range)
23 Days (12 to 71)
25 Days (13 to 149)
0.132